Microsoft contracts Invenergy for solar energy center development
Category: #headlines  By Nikita Chaurasia  Date: 2019-03-08
  • share
  • Twitter
  • Facebook
  • LinkedIn

Microsoft contracts Invenergy for solar energy center development

The construction of the energy center is scheduled to start in 2019 and is anticipated to create approximately 500 jobs during construction.

Microsoft, the tech giant recently announced that it has contracted Invenergy, a global developer of sustainable energy solutions a to develop a 74-MW solar project in North Carolina. The project is expected to supply clean energy to Microsoft, deliver jobs and economic investment for Beaufort County and add to the growth of the U.S. solar power industry.

The Wilkinson Solar Energy Center, as the energy system has been dubbed will be constructed, operated and owned by Invenergy which will supply the energy generated at the Wilkinson Solar Energy Center solely to Microsoft. Invenergy has previously been contracted by other corporate customers to develop and deliver more than 1,600 MW of renewable energy. A power purchase agreement has been signed between Invenergy and Microsoft which is reportedly Microsoft’s fourth PPA in the PJM region and brings its total renewable energy portfolio to nearly 1.3 GW.

Brian Janous, general manager of Energy and Sustainability, Microsoft, has been reported to say that Microsoft’s investment in renewable energy is essentially an investment in the future that enables sustainable business growth as well as that of the local communities that can take advantage of the economic benefit supplied by sustainability and also the growth of the clean energy sector. Janous added that Microsoft’s work with companies like Invenergy is integral to its goal of enabling a clean energy future for everyone.

Experst estimate that the Wilkinson Solar Energy Center will generate nearly $20 million in local economic investment via landowner lease payments, tax payments and benefits for employees. The construction of the energy center is scheduled to start in 2019 and is anticipated to create approximately 500 jobs during construction.

Jim Shield, CCO and executive VP, Invenergy, has been reported to say that Invenergy is looking forward to helping leading corporate renewables customers like Microsoft in meeting their operational and sustainability goals. He added that the investment in North Carolina is an indication of the increasingly compelling value that solar power has in meeting energy needs of customers besides creating economic development opportunities for communities.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Trump calls for a $2 trillion budget for U.S. infrastructure growth
Trump calls for a $2 trillion budget for U.S. infrastructure growth
By Nikita Chaurasia

U.S. President Donald Trump has reportedly called for a $2 trillion spending budget to repair the and build new and currently crumbling infrastructure including tunnels, bridges, and roads, seizing on the COVID-19 outbreak as well as interest rates t...

Analytics 4 Life reveals new data backing novel method to predict LVEDP
Analytics 4 Life reveals new data backing novel method to predict LVEDP
By Nikita Chaurasia

Analytics 4 Life, one the leading digital health company committed to improving existing diagnostic pathways, has reportedly presented data on its heart failure research at the ACC’s (American College of Cardiology) 69th Annual Scientific Sessi...

Esperion presents pooled analyses of NEXLETOL & NEXLIZET at ACC.20/WCC
Esperion presents pooled analyses of NEXLETOL & NEXLIZET at ACC.20/WCC
By Nikita Chaurasia

Esperion Therapeutics, a US-based public pharmaceutical company, reportedly unveiled that two pooled data analyses from its 4 Phase 3 clinical studies of NEXLETOL and outcomes from Phase 2 trial of NEXLIZET were showcased during the ACC.20/WCC. In a...